Drugs / Adcal-D3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02457247 | Jun → Aug 2015 | nutritional disorder | Takeda | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adcal-D3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02457247 ↗ |
| Route | Oral | “Adcal-D3 (Calcium 600 mg / 400 IU Vitamin D3), chewable tablets, orally, twice, daily, on Days 1 through 14, followed by, Calcichew D3 500/400 (Calcium 500 mg/400 IU Vitamin...” NCT02457247 ↗ |